论文部分内容阅读
作者报告1974～1980年用抗胸腺细胞球蛋白(ATG)治疗20例严重型再生障碍性贫血(SAA)患者的情况。患者:均符合Camitta的SAA诊断标准。其中男6例,女14例。中数年龄32(13～84)岁,原因不明18例,继发于肝炎后及药物各1例。从诊断到ATG治疗的中数间隔期为2.5(1～31)个月。治疗方法:分别使用三种制剂:R-ATG、H_1-ATG、H_2-ATG,每天剂量各为3～5、15、
The authors report the treatment of 20 patients with severe forms of aplastic anemia (SAA) with anti-thymocyte globulin (ATG) from 1974 to 1980. Patients: All met Camitta’s SAA diagnostic criteria. Including 6 males and 14 females. The median age of 32 (13 to 84) years of age, unexplained 18 cases, secondary to hepatitis and 1 case of drugs. The median interval from diagnosis to ATG treatment was 2.5 (1 to 31) months. Treatment methods: three kinds of preparations were used: R-ATG, H_1-ATG, H_2-ATG, daily doses of 3 to 5,15,